Wave Life Sciences (WVE)
Prezzo: 5.87Società e modello di business
Wave Life Sciences is a biotechnology company focused on developing therapies for genetic diseases. Its core products include RNA-targeted medicines, with a primary emphasis on treating conditions such as Duchenne muscular dystrophy and other rare diseases. The company operates in the healthcare sector, generating revenue primarily through research and development collaborations and potential future product sales.
Profilo di investimento
The investment profile of Wave Life Sciences is more aligned with growth investors due to its focus on innovative therapies and potential for significant revenue increases. However, the high risk associated with its current financial performance and market volatility suggests caution. The stock may appeal to those with a medium to long-term investment horizon who are comfortable with higher risk levels.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- -1.06 Rischio
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- 121.8% ↑
- Sorpresa EPS
- 61.8% meglio del previsto
- Volatilità 20g
- 3.5% stabile
Impatto della previsione
positivoTraccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-05-28 03:37 | Mantieni | Vendi | scenario_deterioration |
| 2026-05-24 02:55 | Vendi | Mantieni | Weak fundamentals and negative momentum raise significant risk. |
| 2026-05-08 15:20 | — | Vendi | Weak momentum and high risk offset potential gains. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-06-11 10:43 | New Street | Aggiorna | — → 13 | 5.66 |
| 2026-05-20 10:29 | Wells Fargo | Target alzato | 13 → 14 | 6.14 |
| 2026-05-19 10:44 | H.C. Wainwright | Target abbassato | 18 → 13 | 6.4 |
Ancora nulla